Clinical studies recruiting near Jacksonville Beach

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05987241 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · Vertex Pharmaceuticals Incorporated · NCT05312879 Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarc
Phase 3 · Children's Oncology Group · NCT05304585 DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in
Phase 2 · Incannex Healthcare Ltd · NCT07635563 Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Phase 4 · Duke University · NCT04262206 A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Phase 3 · Children's Oncology Group · NCT05382338 Project: Every Child for Younger Patients With Cancer
Phase N/A · Children's Oncology Group · NCT02402244 RA-PRO PRAGMATIC TRIAL
Phase 3 · University of Alabama at Birmingham · NCT04692493 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · SWOG Cancer Research Network · NCT03851445 A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Phase 2 · Eli Lilly and Company · NCT07589595 Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
NA · Shockwave Medical, Inc. · NCT05102019 A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in H
Phase 2 · Children's Oncology Group · NCT06410209 A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Phase 3 · National Cancer Institute (NCI) · NCT04166409 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · NRG Oncology · NCT04852887 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478 A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Phase 2 · Children's Oncology Group · NCT04684368 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · SWOG Cancer Research Network · NCT03723928 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902 Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adu
Phase 3 · Pfizer · NCT07222566 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Merz Therapeutics GmbH · NCT07018700 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · SWOG Cancer Research Network · NCT04511013 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · Merz Therapeutics GmbH · NCT07018713 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · Eli Lilly and Company · NCT07282600 A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acu
Phase 2 · National Cancer Institute (NCI) · NCT04546399 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Phase 2 · Alliance for Clinical Trials in Oncology · NCT02523014 A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NA · Cleerly, Inc. · NCT06112418 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · ECOG-ACRIN Cancer Research Group · NCT02734537 Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Res
Phase 1 · National Cancer Institute (NCI) · NCT04585958

Look up another city

Look up another condition